All about medicine, medical articles.

Micromet Presents Update At ASCO 2009 On A Phase 1b Combination Study Of Adecatumumab And Docetaxel

Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, presented data from a clinical trial investigating its anti-EpCAM human antibody adecatumumab (MT201) in combination with the chemotherapeutic docetaxel in patients with metastatic breast cancer (MBC) at the annual meeting of the American Society of Clinical Oncology (ASCO) held in Orlando, Florida, USA(1).
diet pills

14.3 Million Midwives, Nurses And Doctors Demand Action On Maternal Deaths At July G8 Summit

In an unprecedented move today, millions of midwives, nurses and doctors across the world delivered a message to G8 leaders to take urgent action to prevent women dying needlessly in pregnancy and childbirth.

News of the day

Sanofi Pasteur Receives Order From U.S. Government To Produce New Influenza A(H1N1) Vaccine

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced it has received the first of what is expected to be a series of orders from the U.S. Department of Health and Human Services (HHS) to commence production of a vaccine to help protect against the new influenza A(H1N1) virus.